{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:07:09Z","timestamp":1794049629984,"version":"4.8.0"},"reference-count":34,"publisher":"Cambridge University Press (CUP)","issue":"5","license":[{"start":{"date-parts":[[2013,1,28]],"date-time":"2013-01-28T00:00:00Z","timestamp":1359331200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Nutr"],"published-print":{"date-parts":[[2013,9,14]]},"abstract":"<jats:p>Guanidinoacetic acid (GAA) is the natural biosynthetic precursor of creatine, in a metabolic reaction that requires only a methyl group transfer. The use of GAA as a food additive for restoring creatine load in human tissues is rather unexplored and data on efficacy and safety are limited. In particular, an increase in serum homocysteine after GAA administration can be regarded as critical and should be prevented. The present study evaluated the effects of orally administered GAA with and without methyl group donors on serum and urine creatine concentrations, and the occurrence of adverse events during an intervention in healthy human subjects. A total of twenty male and female volunteers were randomised in a double-blind design to receive either GAA (2\u00b74\u00a0g\/d) or GAA with methyl donors (2\u00b74\u00a0g\/d of GAA and 1\u00b76\u00a0g\/d of betaine HCl, 5\u00a0\u03bcg\/d of vitamin B<jats:sub>12<\/jats:sub>, 10\u00a0mg\/d of vitamin B<jats:sub>6<\/jats:sub>and 600\u00a0\u03bcg\/d of folic acid) by oral administration for 8 weeks. Serum and urine creatine increased significantly from before to after administration in both groups (<jats:italic>P<\/jats:italic>&lt;\u00a00\u00b7001). The proportion of participants who reported minor adverse events was 33\u00b73\u00a0% in the GAA group, and 10\u00b70\u00a0% in the GAA with methyl donors group (<jats:italic>P<\/jats:italic>=\u00a00\u00b730). Hyperhomocysteinaemia was found in 55\u00b76\u00a0% of participants supplemented with GAA, while no participant experienced hyperhomocysteinaemia in the group supplemented with GAA and methyl donors (<jats:italic>P<\/jats:italic>=\u00a00\u00b701). In summary, both interventions strongly influenced creatine metabolism, resulting in a significant increase in fasting serum creatine. The concomitant supplementation of methyl donors along with GAA largely precluded the elevation of serum homocysteine caused by GAA administration alone.<\/jats:p>","DOI":"10.1017\/s0007114512005879","type":"journal-article","created":{"date-parts":[[2013,1,28]],"date-time":"2013-01-28T11:18:47Z","timestamp":1359371927000},"page":"865-870","source":"Crossref","is-referenced-by-count":34,"title":["Co-administration of methyl donors along with guanidinoacetic acid reduces the incidence of hyperhomocysteinaemia compared with guanidinoacetic acid administration alone"],"prefix":"10.1017","volume":"110","author":[{"given":"Sergej M.","family":"Ostojic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Niess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Stojanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milos","family":"Obrenovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2013,1,28]]},"reference":[{"key":"S0007114512005879_ref16","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/archinternmed.2010.348","article-title":"Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality","volume":"170","author":"Clarke","year":"2010","journal-title":"Arch Intern Med"},{"key":"S0007114512005879_ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-004-0075-3"},{"key":"S0007114512005879_ref1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/9780470122952.ch4","article-title":"Creatine: biosynthesis, regulation, function","volume":"50","author":"Walker","year":"1979","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"S0007114512005879_ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.03001.x"},{"key":"S0007114512005879_ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.66019.x"},{"key":"S0007114512005879_ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/80.3.539"},{"key":"S0007114512005879_ref18","first-page":"863","article-title":"Use of betaine and glycocyamine in the treatment of patients with heart disease: preliminary report","volume":"5","author":"Graybiel","year":"1951","journal-title":"Ann West Med Surg"},{"key":"S0007114512005879_ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.11.1455"},{"key":"S0007114512005879_ref7","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114508162985"},{"key":"S0007114512005879_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(56)90154-4"},{"key":"S0007114512005879_ref30","doi-asserted-by":"publisher","DOI":"10.2174\/157488410790410551"},{"key":"S0007114512005879_ref11","doi-asserted-by":"publisher","DOI":"10.1271\/bbb.80543"},{"key":"S0007114512005879_ref19","first-page":"423","article-title":"Betaine and glycocyamine in the treatment of disability resulting from acute anterior poliomyelitis","volume":"6","author":"Borsook","year":"1952","journal-title":"West Med Surg"},{"key":"S0007114512005879_ref8","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.2001.281.5.E1095"},{"key":"S0007114512005879_ref10","doi-asserted-by":"publisher","DOI":"10.1271\/bbb.70791"},{"key":"S0007114512005879_ref13","doi-asserted-by":"publisher","DOI":"10.1007\/PL00014300"},{"key":"S0007114512005879_ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-010-9088-4"},{"key":"S0007114512005879_ref20","first-page":"338","article-title":"Therapy in anxiety states and anxiety complicated by depression","volume":"62","author":"Dixon","year":"1954","journal-title":"West J Surg Obstet Gynecol"},{"key":"S0007114512005879_ref17","first-page":"830","article-title":"Treatment of cardiac decompensation with betaine and glycocyamine","volume":"5","author":"Borsook","year":"1951","journal-title":"Ann West Med Surg"},{"key":"S0007114512005879_ref34","unstructured":"Commission Directive 2008\/100\/EC of 28 October 2008 amending Council Directive 90\/496\/EEC on nutrition labeling for foodstuffs as regards recommended daily allowances, energy conversion factors and definitions."},{"key":"S0007114512005879_ref24","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/clinchem\/48.10.1772","article-title":"Guanidinoacetate and creatine plus creatinine assessment in physiologic fluids: an effective diagnostic tool for the biochemical diagnosis of arginine:glycine amidinotransferase and guanidinoacetate methyltransferase deficiencies","volume":"48","author":"Carducci","year":"2002","journal-title":"Clin Chem"},{"key":"S0007114512005879_ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-010-9151-1"},{"key":"S0007114512005879_ref23","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-5-199909070-00003"},{"key":"S0007114512005879_ref3","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011908606819"},{"key":"S0007114512005879_ref29","doi-asserted-by":"publisher","DOI":"10.1586\/ern.09.75"},{"key":"S0007114512005879_ref26","volume-title":"Handbook of Diagnostic Tests","year":"2003"},{"key":"S0007114512005879_ref32","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2001.126"},{"key":"S0007114512005879_ref25","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2007.099648"},{"key":"S0007114512005879_ref33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032739"},{"key":"S0007114512005879_ref2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2000.80.3.1107"},{"key":"S0007114512005879_ref12","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nutr.19.1.217"},{"key":"S0007114512005879_ref21","first-page":"14","article-title":"Effects of creatine precursors in arthritis: clinical and metabolic study of glycocyamine and betaine","volume":"77","author":"Higgins","year":"1952","journal-title":"Calif Med"},{"key":"S0007114512005879_ref9","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/136.11.2797"},{"key":"S0007114512005879_ref5","first-page":"102","article-title":"Oral creatine supplements lower plasma homocysteine concentrations in humans","volume":"17","author":"Korzun","year":"2004","journal-title":"Clin Lab Sci"}],"container-title":["British Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007114512005879","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T07:14:07Z","timestamp":1714893247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007114512005879\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,28]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9,14]]}},"alternative-id":["S0007114512005879"],"URL":"https:\/\/doi.org\/10.1017\/s0007114512005879","relation":{},"ISSN":["0007-1145","1475-2662"],"issn-type":[{"value":"0007-1145","type":"print"},{"value":"1475-2662","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,28]]}}}